Literature DB >> 10611747

T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii.

E Y Denkers1.   

Abstract

Immunity to the opportunistic pathogen, Toxoplasma gondii, is highly dependent upon the effector activity of IFN-gamma-producing T lymphocytes. While IFN-gamma is required to survive infection, an understanding of its function remains incomplete. During infection, T. gondii simultaneously induces downregulatory antiinflammatory cytokines, thereby avoiding major host pathology mediated by proinflammatory cytokines such as IFN-gamma. The ability to induce the correct balance between these two opposing host responses likely accounts for the success of this organism as a parasite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611747     DOI: 10.1016/s1286-4579(99)80071-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  23 in total

1.  Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.

Authors:  W Däubener; B Spors; C Hucke; R Adam; M Stins; K S Kim; H Schroten
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

3.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

4.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

5.  Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.

Authors:  Ki-Man Kang; Gye-Sung Lee; Jae-Ho Lee; In-Wook Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2004-12       Impact factor: 1.341

6.  TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production.

Authors:  Michael J Brumlik; Srilakshmi Pandeswara; Sara M Ludwig; Duane P Jeansonne; Michelle R Lacey; Kruthi Murthy; Benjamin J Daniel; Rong-Fu Wang; Suzanne R Thibodeaux; Kristina M Church; Vincent Hurez; Mark J Kious; Bin Zhang; Adebusola Alagbala; Xiaojun Xia; Tyler J Curiel
Journal:  Exp Parasitol       Date:  2013-03-27       Impact factor: 2.011

Review 7.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

8.  Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection.

Authors:  M B Nickdel; F Roberts; F Brombacher; J Alexander; C W Roberts
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.

Authors:  Young-Ha Lee; Dae-Whan Shin; Jae-Ho Lee; Ho-Woo Nam; Myoung-Hee Ahn
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

10.  Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.

Authors:  Ju Ock Kim; Sung Soo Jung; Sun Young Kim; Tae Yun Kim; Dae Whan Shin; Jae Ho Lee; Young Ha Lee
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.